Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Golgi fragmentation is observed in neurodegenerative disease...

Class:IdSummation:8868335
_displayNameGolgi fragmentation is observed in neurodegenerative disease...
_timestamp2016-04-22 18:44:08
created[InstanceEdit:8868334] Orlic-Milacic, Marija, 2016-04-20
literatureReference[LiteratureReference:8868261] Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease
[LiteratureReference:2245207] Cdc2 kinase directly phosphorylates the cis-Golgi matrix protein GM130 and is required for Golgi fragmentation in mitosis
modified[InstanceEdit:8868339] Orlic-Milacic, Marija, 2016-04-20
[InstanceEdit:8868681] Orlic-Milacic, Marija, 2016-04-22
textGolgi fragmentation is observed in neurodegenerative diseases, including Alzheimer's disease. The underlying mechanism, based on a mouse AD model, is the phosphorylation of the Golgi membrane protein GOLGA2 (GM130) by the CDK5:p25 complex. CDK5:p25 phosphorylates GOLGA2 (GM130) on a conserved residue S37, phosphorylated by CDK1 in mitotic prophase (Lowe et al. 1998), triggering Golgi apparatus disassembly in Alzheimer's disease (Sun et al. 2008). Please note that S37 of GOLGA2 is sometimes labeled as S25 in the literature because the recombinant Golga2 construct used in the original study of mitotic Golgi fragmentation (Lowe et al. 1998) lacked 12 N-terminal amino acids of Golga2.
(summation)[Reaction:8868260] CDK5:p25 phosphorylates GOLGA2 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Golgi fragmentation is observed in neurodegenerative disease... (8868335)